Sun Pharma plans to file new drug application with USFDA: Dilip Shanghvi

Dilip Shanghvi reportedly said that the firm's research arm SPARC (Sun Pharma Advanced Research Company) is currently working on three new drugs that are currently under clinical trial stage.

India's largest drugmaker Sun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years, the company's Managing Director Dilip Shanghvi reportedly said.

Dilip Shanghvi reportedly said that the firm's research arm SPARC (Sun Pharma Advanced Research Company) is currently working on three new drugs that are currently under clinical trial stage. 

"And hopefully in the next two to three years, we should have our own new product registered in the US," Shanghvi said in his address at Indian School of Business.